GNTA · Genenta Science S.p.A. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-03-30 | Sharei Armon |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options vest in equal monthly installments over one year beginning March 30, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2026-03-30 | Mutti Miguel Maria |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options vest in equal monthly installments over one year beginning March 30, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2026-03-30 | Galimi Francesco |
Director, CMO& Head of Development |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options vest in equal monthly installments over one year beginning March 30, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2026-03-30 | Pierluigi Paracchi |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options vest in equal monthly installments over three years beginning March 30, 2026. |
Stock Option (right to buy)
|
100,000 |
| 2026-03-30 | PARACCHI GIACOMOANTONIO |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options vest in equal monthly installments over one year beginning March 30, 2026. |
Stock Option (right to buy)
|
20,000 |
| 2026-03-30 | SLANSKY RICHARD B |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock options vest in equal monthly installments over three years beginning March 30, 2026. |
Stock Option (right to buy)
|
80,000 |